FDA Inspection
Baxalta Belgium Manufacturing SABaxalta Belgium Manufacturing SA – FDA Inspection, Jan 19, 2017
Record Details
This FDA Inspection record concerns Baxalta Belgium Manufacturing SA, with an inspection on January 19, 2017, issued by the Office of Inspections and Investigations, covering biologics.
View Company Profile
ID · cb7403f5-accc-4793-a288-4c414f40d735
Inspection Facts
- Inspection number
- 1021112
- FDA center
- Biologics
- Outcome
- Form 483 issued
Other FDA inspections of Baxalta Belgium Manufacturing SA
7| Date | Classification | Office | Project area |
|---|---|---|---|
| November 22, 2024 | VAI | Office of Inspections and Investigations | Blood and Blood Products |
| May 31, 2019 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 24, 2015 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 18, 2013 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| March 19, 2013 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Baxalta Belgium Manufacturing SA
- FDA Inspection 1251969 - 2024-11-22
- FDA Inspection 1093550 - 2019-05-31
- FDA Inspection 918229 - 2015-02-24
- FDA Inspection 841219 - 2013-06-18
- FDA Inspection 827427 - 2013-03-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.